TWA
TXG icon

TCI Wealth Advisors’s 10x Genomics TXG Stock Holding History

TCI Wealth Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16
Closed -$893 – 2098
2023
Q1 		$893 Hold
16
– – ﹤0.01% 2127
2022
Q4 		$583 Hold
16
– – ﹤0.01% 2197
2022
Q3 		$0 Buy
+16
New +$610 ﹤0.01% 2592
2022
Q2 		– Sell
-7
Closed -$1K – 2518
2022
Q1 		$1K Hold
7
– – ﹤0.01% 2156
2021
Q4 		$1K Sell
7
-33
-83% -$5.05K ﹤0.01% 2242
2021
Q3 		$6K Buy
40
+22
+122% +$3.78K ﹤0.01% 1520
2021
Q2 		$4K Hold
18
– – ﹤0.01% 1642
2021
Q1 		$3K Hold
18
– – ﹤0.01% 1599
2020
Q4 		$3K Sell
18
-3
-14% -$435 ﹤0.01% 1142
2020
Q3 		$3K Buy
21
+14
+200% +$1.47K ﹤0.01% 1014
2020
Q2 		$1K Buy
+7
New +$545 ﹤0.01% 1371

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

TCI Wealth Advisors's TXG Position: Q2 2023 in Review

TCI Wealth Advisors sold out of 10x Genomics (TXG) in Q2 2023, closing a stake of 16 shares — an estimated $893 sold.

TCI Wealth Advisors first reported a position in TXG in Q2 2020 and held it in 11 quarters. The position peaked at $6K in Q3 2021. 274 funds tracked by Wall St. Rank hold TXG as of Q2 2023.

  • TCI Wealth Advisors reported no remaining 10x Genomics position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 16 10x Genomics shares in Q2 2023, an estimated $893.
  • TCI Wealth Advisors first reported a position in 10x Genomics in Q2 2020 and held it in 11 quarters.
  • TCI Wealth Advisors's 10x Genomics position peaked at $6K in Q3 2021.
  • 274 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.